Topic Review
Oxidative Stress Markers
Reactive oxygen species (ROS) have deleterious effects on cell components (protein-derived enzymes, lipid-rich membranes, nucleic acids, and carbohydrates), causing functional and structural alterations. Depending on the molecular targets of ROS action, oxidative stress (OS) markers show a wide variety. Therefore, they can be divided into four main classes: markers of lipid peroxidation, DNA oxidative damage, protein oxidation, and carbohydrate oxidation. The antioxidant molecules also represent an important source of biomarkers to evaluate OS.
  • 775
  • 05 Sep 2023
Topic Review Peer Reviewed
Kidney Issues Associated with COVID-19 Disease
Infection with SARS-CoV-2 and the resulting COVID-19 can cause both lung and kidney damage. SARS-CoV-2 can directly infect renal cells expressing ACE2 receptors, resulting in kidney damage, and acute kidney injury (AKI) has been reported in COVID-19 hospitalized patients. The pathophysiology of COVID-19-associated AKI is multifactorial. Local and systemic inflammation, immune system dysregulation, blood coagulation disorders, and activation of the renin-angiotensin-aldosterone system (RAAS) are factors that contribute to the development of AKI in COVID 19 disease. COVID-19 patients with kidney involvement have a poor prognosis, and patients with chronic kidney disease (CKD) infected with SARS-CoV-2 have an increased mortality risk. CKD patients with COVID-19 may develop end-stage renal disease (ESRD) requiring dialysis. In particular, patients infected with SARS-CoV-2 and requiring dialysis, as well as patients who have undergone kidney transplantation, have an increased risk of mortality and require special consideration. Nephrologists and infectious disease specialists face several clinical dilemmas in the prophylaxis and treatment of CKD patients with COVID-19. This entry presents recent data showing the effects of COVID-19 on the kidneys and CKD patients and the challenges in the management of CKD patients with COVID-19, and discusses treatment strategies for these patients.
  • 557
  • 05 Sep 2023
Topic Review
Oral Complications in Children with Acute Lymphoblastic Leukemia
Acute lymphocytic leukemia (ALL) is the most frequent form of all childhood leukemias, mostly affecting children between 2 and 4 years old. Oral symptoms, such as mouth ulcers, mucositis, xerostomia, Herpes or Candidiasis, gingival enlargement and bleeding, petechiae, erythema, mucosal pallor and atrophic glossitis, are very common symptoms of ALL and can be early signs of the disease.
  • 238
  • 05 Sep 2023
Topic Review
C-Reactive Protein as Inflammatory Marker in Cardiovascular Disease
C-reactive protein (CRP) is an inflammatory molecule that has demonstrated value as a predictive marker for cardiovascular risk assessment, both independently and in conjunction with other parameters. It has been incorporated into risk assessment algorithms, enhancing risk prediction and guiding therapeutic decisions. Pharmacological interventions with anti-inflammatory properties, such as statins, glucagon-like peptide-1 agonists, and interleukin-1 inhibitors, have shown promising effects in reducing both cardiovascular risks and CRP levels.
  • 166
  • 05 Sep 2023
Topic Review
Treatment of Rectal Cancer
Rectal cancer poses a substantial healthcare challenge, emphasizing the critical need for effective treatment strategies. Among the various approaches available, surgical intervention, notably total mesorectal excision (TME), stands as the gold standard for rectal cancer management, consistently delivering exceptional oncological results. In certain instances of early-stage disease, endoscopic treatments and transanal resection techniques may be viable options, offering a more conservative approach. Additionally, for cases characterized by locally advanced tumors, radiotherapy has demonstrated significant benefits in augmenting the overall treatment efficacy.
  • 432
  • 04 Sep 2023
Topic Review
Intracranial Neurofeedback System on Memory Function
Neurofeedback (NF) shows promise in enhancing memory, but its application to the medial temporal lobe (MTL) still needs to be studied. Twenty trials of a tug-of-war game per session were employed for NF and designed to control neural activity bidirectionally (Up/Down condition).
  • 212
  • 04 Sep 2023
Topic Review
Intravenous Iron Therapy to Treat Anemia in Oncology
Anemia is a common problem when patients present with cancer, and it can worsen during treatment. Anemia can directly impact the cognitive and physical quality of life and may impair fitness for oncological therapy. The most common cause of anemia is iron deficiency. Newer intravenous (IV) iron formulations offer a safe and rapidly effective treatment option. 
  • 266
  • 04 Sep 2023
Topic Review
Decoding Neurodegeneration
Neurodegenerative disorders often acquire due to genetic predispositions and genomic alterations after exposure to multiple risk factors. The most commonly found pathologies are variations of dementia, such as frontotemporal dementia and Lewy body dementia, as well as rare subtypes of cerebral and cerebellar atrophy-based syndromes. In an emerging era of biomedical advances, molecular–cellular studies offer an essential avenue for a thorough recognition of the underlying mechanisms and their possible implications in the patient’s symptomatology. 
  • 297
  • 04 Sep 2023
Topic Review
Proteome of Extracellular Vesicles in Breast Cancer
Breast cancer (BC) accounts for the highest incidence of tumor-related mortality among women worldwide, justifying the growing search for molecular tools for the early diagnosis and follow-up of BC patients under treatment. Circulating extracellular vesicles (EVs) are membranous nanocompartments produced by all human cells, including tumor cells. 
  • 171
  • 04 Sep 2023
Topic Review
Cytoskeleton during Late Steps of HIV-1 Life Cycle
HIV-1 has evolved a plethora of strategies to overcome the cytoskeletal barrier (i.e., actin and intermediate filaments (AFs and IFs) and microtubules (MTs)) to achieve the viral cycle. HIV-1 modifies cytoskeletal organization and dynamics by acting on associated adaptors and molecular motors to productively fuse, enter, and infect cells and then traffic to the cell surface, where virions assemble and are released to spread infection. The HIV-1 envelope (Env) initiates the cycle by binding to and signaling through its main cell surface receptors (CD4/CCR5/CXCR4) to shape the cytoskeleton for fusion pore formation, which permits viral core entry. Then, the HIV-1 capsid is transported to the nucleus associated with cytoskeleton tracks under the control of specific adaptors/molecular motors, as well as HIV-1 accessory proteins. Furthermore, HIV-1 drives the late stages of the viral cycle by regulating cytoskeleton dynamics to assure viral Pr55Gag expression and transport to the cell surface, where it assembles and buds to mature infectious virions. 
  • 520
  • 04 Sep 2023
  • Page
  • of
  • 1349
Video Production Service